Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial

Metabolic Syndrome, Insulin Resistance, and Roles of Inflammation – Mechanisms and Therapeutic Targets

(2012) Giulio R. Romeo et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Effect of Insulin Sensitizer Therapy on Atherothrombotic and Inflammatory Profiles Associated With Insulin Resistance

(2012) Rozalina G. McCoy et al.   MAYO CLINIC PROCEEDINGS

Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance

(2012) Ilias Stagakis et al.   ARTHRITIS RESEARCH & THERAPY

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study

(2012) L. Azoulay et al.   BMJ-British Medical Journal

Pioglitazone improves the cardiovascular profile in patients with uncomplicated systemic lupus erythematosus: a double-blind randomized clinical trial

(2011) JG Juárez-Rojas et al.   LUPUS

The Role of T cell PPAR γ in mice with experimental inflammatory bowel disease

(2010) Amir J Guri et al.   BMC GASTROENTEROLOGY

Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes

(2010) R. E. Aubert et al.   DIABETES OBESITY & METABOLISM

Inflammation‐associated insulin resistance: Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms

(2008) Cecilia P. Chung et al.   ARTHRITIS AND RHEUMATISM

Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis

(2008) Meriem Koufany et al.   ARTHRITIS RESEARCH & THERAPY

Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis

(2007) Cecilia P. Chung et al.   ATHEROSCLEROSIS